StemCells, Inc. (NASDAQ:STEM) stock surged 17.97% to $2.56 in the pre-market hour after the company announced that interim six-month data from the first patient cohort in the Company's Phase I/II clinical trial of its proprietary HuCNS-SC product candidate (purified human neural stem cells) for chronic spinal cord injury continues to demonstrate a favorable safety profile, and shows considerable gains in sensory function in two of the three patients compared to pre-transplant baselines.
Should Investors Buy STEM After Today’s Gain? Find Out Here
Facebook Inc (NASDAQ:FB) shares climbed 0.68% to $18.18 in pre-market hour. Wolfram Alpha has made an initiative to recollect all this information, whatever your friends allow you to see, and created a mystifying spread of data associated to your Facebook (FB) usage.
Additionally, the company’s shareholders are continuously concerned about the revenue flow from which the company can take benefit.
Should Investors Buy FB After The Recent Slump? Find Out Here
Spectrum Brands Holdings, Inc. (NYSE:SPB) announced that its Rayovac global battery division will make another multi-million dollar investment over the next year in research and development and in its manufacturing plants to meet growing demand for the world's longest-lasting, mercury-free hearing aid batteries.
First PacTrust Bancorp, Inc. (NASDAQ:BANC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 per share on its outstanding common stock. The dividend will be payable on October 1, 2012 to shareholders of record as of September 14, 2012.
Campbell Soup Company (NYSE:CPB) shares gained 4.44% to $36.70 in the pre-market hour after the company posted fourth quarter net income of $127 million, or $0.40 per share, from $100 million, or $0.31 per share, in the same period a year earlier. Adjusted earnings were $0.41 per share, topping analysts' average estimate of $0.38 a share. Sales were flat at $1.61 billion. Campbell forecast adjusted earnings of $2.51 to $2.57 per share for fiscal 2013 and sales growth of 10 to 12 percent. Analysts were expecting $2.52 per share.
Additionally, the company said that it expects fiscal 2013 sales to grow between 10%-12%, adjusted EBIT between 4%-6% and adjusted EPS between 3%-5% and adjusted EPS to be between $2.51-$2.57. The Company reported sales of $7.7 Billion, EBIT of $1.2 billion in fiscal 2012.